Vaccines

21 Jun 2017 ImmunoCellular Therapeutics Provides Update on Strategic Review and Decision to Suspend Further Patient Randomization for ICT-107 Phase 3 Trial
21 Jun 2017 GSK presents positive results from Phase III revaccination study of its candidate shingles vaccine Shingrix at CDC's Advisory Meeting
21 Jun 2017 NanoBio And Porton Biopharma Receive Approval To Advance Next Generation Anthrax Vaccine
21 Jun 2017 Genexine Receives Approval to Initiate Phase Ib/II Trial of GX-188E, HPV Therapeutic DNA Vaccine, in Combination With KEYTRUDA® (pembrolizumab), for the Treatment of HPV-Induced Cervical Cancer
21 Jun 2017 Pfizer Begins Phase 1 Clinical Trial to Evaluate Investigational Group B Streptococcus Vaccine
15 Jun 2017 Inovio Fully Enrolls 160 Subjects in Puerto Rico for Second Zika Vaccine Phase 1 Trial; Continues Leadership to Advance an Effective Preventive Solution
13 Jun 2017 Aimmune Therapeutics Reports on Up-Dosing in Its Ongoing Phase 3 PALISADE Trial of AR101 for Peanut Allergy
13 Jun 2017 Autoantigen GAD-Vaccine is Safe for Children at High Risk for Developing Type 1 Diabetes
11 Jun 2017 Inovio Begins Phase 3 Clinical Trial of VGX-3100 for the Treatment of HPV-Related Cervical Pre-Cancer
07 Jun 2017 AFFiRiS announces top line results of first-in-human clinical study using Affitope® PD03A, confirming immunogenicity and safety profile in Parkinson's disease patients
06 Jun 2017 NIH and Themis Bioscience announce the initiation of a clinical trial of a Chikungunya vaccine
06 Jun 2017 ImmunoCellular Therapeutics Announces Data from ICT-121 Phase 1 Trial in Recurrent Glioblastoma at ASCO 2017
05 Jun 2017 Heat Biologics Presents Poster on its Phase 2 Trial Evaluating HS-410 at ASCO Annual Meeting
05 Jun 2017 Immune Design Updates Positive Data from Lead Cancer Immunotherapy Programs at ASCO Annual Meeting
04 Jun 2017 Dendreon Announces New Findings Demonstrating Durable and Robust Killer T-Cell Response with PROVENGE
04 Jun 2017 NovaDigm Therapeutics Awarded $6 Million by U.S. Department of Defense to Conduct a Phase 2a Staphylococcus aureus Vaccine Trial
02 Jun 2017 Inovio Announces Clinical Trial Collaboration to Evaluate a Novel T-cell Immunotherapy in Combination with a PD-L1 Checkpoint Inhibitor
01 Jun 2017 Vaxon announces results of its Phase IIb lung cancer trial of Vx-001, a therapeutic vaccine based on optimized cryptic peptides
30 May 2017 European Commission Approves Pfizer’s TRUMENBA® to Help Prevent Meningococcal Group B Disease in Adolescents and Adults
30 May 2017 Imcyse obtains authorization to launch Phase 1b trial in Type 1 diabetes
24 May 2017 Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study
23 May 2017 United Neuroscience Reports Positive Phase 1 Results for Active Vaccine UB-311 in Alzheimer’s Disease
18 May 2017 VAXIMM Announces Data from Phase I Trial in Glioblastoma with Oral T-cell Immunotherapy VXM01 to be Presented at ASCO 2017 Annual Meeting
14 May 2017 Dendreon Announces Results of New PROCEED Registry Analysis Showing Overall Survival Benefit with PROVENGE® in Men with Metastatic Prostate Cancer
11 May 2017 Aimmune Therapeutics Enrolls First Patient in RAMSES (ARC007), a Phase 3 Clinical Trial of AR101 for the Treatment of Peanut Allergy

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top